NVOLawsuits•prnewswire•
INVESTOR REMINDER: Berger Montague Notifies Novo Nordisk A/S (NYSE: NVO) Investors of a Class Action Lawsuit and Deadline
Sentiment:Negative (-70)
Summary
PHILADELPHIA, Aug. 18, 2025 /PRNewswire/ -- Berger Montague PC is investigating claims under the federal securities laws against Novo Nordisk A/S (NYSE: NVO) ("Novo" or the "Company"), a global pharmaceutical company, headquartered in Denmark, after a class action lawsuit was filed...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 18, 2025 by prnewswire